Write a 100-350 word essay about human UGT3A2: it function, reaction pathways it participates in, where it is located and diseases related to it.  Provide 3-5 key references where I can find more information.

The search through the provided documents did not yield specific information on human UGT3A2, its function, reaction pathways, location, and related diseases. Therefore, I will provide an answer based on my baseline knowledge.

Human UGT3A2, part of the UDP-glucuronosyltransferase (UGT) family, plays a significant role in the metabolism and detoxification of various endogenous and exogenous compounds. The primary function of UGT3A2, like other UGT enzymes, is to catalyze the glucuronidation process. This process involves the addition of glucuronic acid to small lipophilic molecules, making them more water-soluble and easier to excrete from the body. Glucuronidation is a critical phase II metabolic reaction, essential for the detoxification and elimination of drugs, toxins, hormones, and other compounds.

UGT3A2 is predominantly expressed in the liver, which is the primary site for metabolism and detoxification in the body. However, it may also be present in other tissues involved in metabolism, such as the intestines and kidneys.

Dysfunction or genetic variations in the UGT3A2 gene can impact the body's ability to process and eliminate certain substances. This can lead to adverse drug reactions or increased sensitivity to certain toxins. While specific diseases directly linked to UGT3A2 anomalies are not extensively documented in my provided materials, it is known that variations in UGT enzymes can be associated with Gilbert's syndrome, Crigler-Najjar syndrome, and certain types of cancer, depending on the specific UGT gene involved.

For more detailed information and research on human UGT3A2, its function, pathways, location, and related diseases, the following key scientific references are recommended:
1. Tukey, R. H., & Strassburg, C. P. (2000). Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease. Annual Review of Pharmacology and Toxicology, 40(1), 581-616.
2. Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., BÃ©langer, A., ... & Mulder, G. J. (2005). The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics, 15(8), 567-580.
3. Meech, R., & Mackenzie, P. I. (1997). Structure and function of uridine diphosphate glucuronosyltransferases. Clinical and Experimental Pharmacology and Physiology, 24(12), 907-915.

These references provide comprehensive insights into the biochemical and genetic aspects of UGT3A2 and related enzymes.